Identification of antigen and adjuvant doses resulting in optimal immunogenicity and antibody persistence up to 1 year after immunization with a pandemic A/H1N1 influenza vaccine in children 3 to < 9 years of age. (Q30414308)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Identification of antigen and adjuvant doses resulting in optimal immunogenicity and antibody persistence up to 1 year after immunization with a pandemic A/H1N1 influenza vaccine in children 3 to < 9 years of age. |
scientific article |
Statements
1 reference
Identification of antigen and adjuvant doses resulting in optimal immunogenicity and antibody persistence up to 1 year after immunization with a pandemic A/H1N1 influenza vaccine in children 3 to < 9 years of age. (English)
1 reference
Cynthia Nassim
1 reference
Shane Christensen
1 reference
Dan Henry
1 reference
Sandra Holmes
1 reference
Matthew Hohenboken
1 reference
Niranjan Kanesa-Thasan
1 reference
1 reference